A Transdiagnostic Internet Intervention for Parents of Children With Anxiety and Depressive Symptoms (ParentKIT)

September 12, 2023 updated by: Costina-Ruxandra Păsărelu, Babes-Bolyai University

Digital Parent-led Transdiagnostic Interventions for Child and Adolescent Anxiety and Depressive Disorders

The purpose of this study is to evaluate the efficacy of a transdiagnostic, parent-led, Internet-delivered intervention in reducing child and adolescent internalizing problems.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Anxiety and depressive symptoms are common in children and adolescents. There is substantial research indicating that transdiagnostic Internet interventions are effective for adults and children with anxiety and depressive disorders; however, there is limited research on the efficacy of such programs aimed at parents of children and adolescents with anxiety and depressive symptoms. This study aims to investigate the efficacy of a transdiagnostic Internet intervention for parents of children with elevated anxiety and depressive symptoms.

Study Type

Interventional

Enrollment (Actual)

111

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cluj-Napoca, Romania, 400015
        • Babes-Bolyai University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 14 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • parent of a child/ adolescent aged 6 to 14 years
  • elevated internalizing problems
  • have Internet access

Exclusion Criteria:

  • undergoing psychotherapy/ pharmacological treatment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: ParentKIT
Transdiagnostic parent-led Internet-delivered intervention Participants in the experimental group will have access to the ParentKIT intervention. The intervention was developed based on existing Cognitive Behavioral Therapy/ Rational Emotive Behavior Therapy protocols for parents of children with internalizing problems. It consists of nine modules delivered over three weeks.
The intervention is structured in 9 modules through which parents learn to identify and manage their children's anxiety and depressive symptoms. The Internet intervention is guided by two psychotherapists under supervision training in Cognitive Behavioral Therapy, trained by the first author on the treatment protocol.
No Intervention: Waitlist
Participants in the waitlist condition will have access to the program after 3 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in the brief Revised Children's Anxiety and Depression Scale - parent version
Time Frame: Baseline, 3 weeks and follow-up at 1 month after treatment termination
Measure of child anxiety and depressive symptoms, as reported by parents. Scores range between 0 and 33; higher scores indicate higher anxiety and depressive symptoms.
Baseline, 3 weeks and follow-up at 1 month after treatment termination

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in the Patient Health Questionnaire-4
Time Frame: Baseline, 3 weeks and follow-up at 1 month after treatment termination
Measure of anxiety and depressive symptoms - will be used to measure changes in parental distress. Scores range between 0 and 12. Higher scores indicate higher distress.
Baseline, 3 weeks and follow-up at 1 month after treatment termination
Change in the Parental Self-Efficacy Scale
Time Frame: Baseline, 3 weeks and follow-up at 1 month after treatment termination
Measure of parental self-efficacy in relationship to parenting practices that may decrease anxiety and depression risks for adolescents. Total scores range between and 9 and 36. Higher scores indicate higher parental self-efficacy.
Baseline, 3 weeks and follow-up at 1 month after treatment termination
Change in the Family Accommodation Scale
Time Frame: Baseline, 3 weeks and follow-up at 1 month after treatment termination
Measure of parental anxiety accommodations. Scores range between 0 and 52. Higher scores indicate higher parental anxiety accommodations.
Baseline, 3 weeks and follow-up at 1 month after treatment termination
Satisfaction with the intervention
Time Frame: 3 weeks after treatment initiation
Client satisfaction will be measured with Client Satisfaction Questionnaire, short form (Attkisson & Zwick, 1982). Scores range from 8 to 32, with higher scores indicating greater satisfaction with the intervention.
3 weeks after treatment initiation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Costina R Păsărelu, Ph.D, Babes-Bolyai University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2022

Primary Completion (Actual)

June 30, 2023

Study Completion (Actual)

August 31, 2023

Study Registration Dates

First Submitted

April 11, 2022

First Submitted That Met QC Criteria

April 16, 2022

First Posted (Actual)

April 22, 2022

Study Record Updates

Last Update Posted (Actual)

September 13, 2023

Last Update Submitted That Met QC Criteria

September 12, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

De-identified data will be uploaded after publication of the results.

IPD Sharing Time Frame

De-identified data will be uploaded after publication of the results.

IPD Sharing Access Criteria

Upon the completion of the study, de-identified datasets will be available from the corresponding author on reasonable request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Subscribe